Development of Ganoderma lucidum spore powder based proteoglycan and its application in hyperglycemic, antitumor and antioxidant function

Li Fang Zhu, Yuanfa Yao, Zeeshan Ahmad, Ming Wei Chang

Research output: Contribution to journalArticle

Abstract

A new natural proteoglycan from Ganoderma lucidum spore powder (GLSP) was obtained via solvent extraction and optimized using response surface methodology (RSM). The differences among the characteristics of the new proteoglycan from cracked (proteoglycan-C) and uncracked GLSP (proteoglycan-UC) were explored. The SDS-PAGE results showed the molecular weight of protein contained in proteoglycan-UC (55, 72, 95 kDa) was different to that proteoglycan-C (43, 95 kDa). The differences of these amino acids (Glu, Arg, Leu and Lys) content and monosaccharides (Fuc, Gal, Glc, Man and Gal-AC) content between proteoglycan-C and proteoglycan-UC were determined by HPLC/ ion chromatography. The 2,2′-azino-bis (3-ethylbenzthiazoline-6-sulphonic acid) (ABTS) and 1,1-Diphenyl-2-picrylhydrazyl (DPPH) radical scavenging activities of proteoglycan-C were higher than that proteoglycan-UC. The proteoglycan-UC exhibited stronger hypoglycemic and antibacterial effects against E. coli and S. aureus, and the proteoglycan-C and proteoglycan-UC showed antitumor effects with potential for therapeutic applications.

LanguageEnglish
Pages103-111
Number of pages9
JournalProcess Biochemistry
Volume84
Early online date23 May 2019
DOIs
Publication statusPublished - 1 Sep 2019

Fingerprint

Reishi
Proteoglycans
Antioxidants
Spores
Powders
Ion chromatography
Sulfonic Acids
Monosaccharides
Scavenging
Solvent extraction
Hypoglycemic Agents
Escherichia coli
Chromatography
Amino acids
Polyacrylamide Gel Electrophoresis

Keywords

  • Antibacterial
  • Antitumor
  • Ganoderma lucidum spore powder
  • Hypoglycemic
  • Proteoglycan

Cite this

@article{4b9cb80fbe2a4e83918669c6af68cb4e,
title = "Development of Ganoderma lucidum spore powder based proteoglycan and its application in hyperglycemic, antitumor and antioxidant function",
abstract = "A new natural proteoglycan from Ganoderma lucidum spore powder (GLSP) was obtained via solvent extraction and optimized using response surface methodology (RSM). The differences among the characteristics of the new proteoglycan from cracked (proteoglycan-C) and uncracked GLSP (proteoglycan-UC) were explored. The SDS-PAGE results showed the molecular weight of protein contained in proteoglycan-UC (55, 72, 95 kDa) was different to that proteoglycan-C (43, 95 kDa). The differences of these amino acids (Glu, Arg, Leu and Lys) content and monosaccharides (Fuc, Gal, Glc, Man and Gal-AC) content between proteoglycan-C and proteoglycan-UC were determined by HPLC/ ion chromatography. The 2,2′-azino-bis (3-ethylbenzthiazoline-6-sulphonic acid) (ABTS) and 1,1-Diphenyl-2-picrylhydrazyl (DPPH) radical scavenging activities of proteoglycan-C were higher than that proteoglycan-UC. The proteoglycan-UC exhibited stronger hypoglycemic and antibacterial effects against E. coli and S. aureus, and the proteoglycan-C and proteoglycan-UC showed antitumor effects with potential for therapeutic applications.",
keywords = "Antibacterial, Antitumor, Ganoderma lucidum spore powder, Hypoglycemic, Proteoglycan",
author = "Zhu, {Li Fang} and Yuanfa Yao and Zeeshan Ahmad and Chang, {Ming Wei}",
year = "2019",
month = "9",
day = "1",
doi = "10.1016/j.procbio.2019.05.025",
language = "English",
volume = "84",
pages = "103--111",
journal = "Process Biochemistry",
issn = "1359-5113",
publisher = "Elsevier",

}

Development of Ganoderma lucidum spore powder based proteoglycan and its application in hyperglycemic, antitumor and antioxidant function. / Zhu, Li Fang; Yao, Yuanfa; Ahmad, Zeeshan; Chang, Ming Wei.

In: Process Biochemistry, Vol. 84, 01.09.2019, p. 103-111.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Development of Ganoderma lucidum spore powder based proteoglycan and its application in hyperglycemic, antitumor and antioxidant function

AU - Zhu, Li Fang

AU - Yao, Yuanfa

AU - Ahmad, Zeeshan

AU - Chang, Ming Wei

PY - 2019/9/1

Y1 - 2019/9/1

N2 - A new natural proteoglycan from Ganoderma lucidum spore powder (GLSP) was obtained via solvent extraction and optimized using response surface methodology (RSM). The differences among the characteristics of the new proteoglycan from cracked (proteoglycan-C) and uncracked GLSP (proteoglycan-UC) were explored. The SDS-PAGE results showed the molecular weight of protein contained in proteoglycan-UC (55, 72, 95 kDa) was different to that proteoglycan-C (43, 95 kDa). The differences of these amino acids (Glu, Arg, Leu and Lys) content and monosaccharides (Fuc, Gal, Glc, Man and Gal-AC) content between proteoglycan-C and proteoglycan-UC were determined by HPLC/ ion chromatography. The 2,2′-azino-bis (3-ethylbenzthiazoline-6-sulphonic acid) (ABTS) and 1,1-Diphenyl-2-picrylhydrazyl (DPPH) radical scavenging activities of proteoglycan-C were higher than that proteoglycan-UC. The proteoglycan-UC exhibited stronger hypoglycemic and antibacterial effects against E. coli and S. aureus, and the proteoglycan-C and proteoglycan-UC showed antitumor effects with potential for therapeutic applications.

AB - A new natural proteoglycan from Ganoderma lucidum spore powder (GLSP) was obtained via solvent extraction and optimized using response surface methodology (RSM). The differences among the characteristics of the new proteoglycan from cracked (proteoglycan-C) and uncracked GLSP (proteoglycan-UC) were explored. The SDS-PAGE results showed the molecular weight of protein contained in proteoglycan-UC (55, 72, 95 kDa) was different to that proteoglycan-C (43, 95 kDa). The differences of these amino acids (Glu, Arg, Leu and Lys) content and monosaccharides (Fuc, Gal, Glc, Man and Gal-AC) content between proteoglycan-C and proteoglycan-UC were determined by HPLC/ ion chromatography. The 2,2′-azino-bis (3-ethylbenzthiazoline-6-sulphonic acid) (ABTS) and 1,1-Diphenyl-2-picrylhydrazyl (DPPH) radical scavenging activities of proteoglycan-C were higher than that proteoglycan-UC. The proteoglycan-UC exhibited stronger hypoglycemic and antibacterial effects against E. coli and S. aureus, and the proteoglycan-C and proteoglycan-UC showed antitumor effects with potential for therapeutic applications.

KW - Antibacterial

KW - Antitumor

KW - Ganoderma lucidum spore powder

KW - Hypoglycemic

KW - Proteoglycan

UR - http://www.scopus.com/inward/record.url?scp=85066097224&partnerID=8YFLogxK

U2 - 10.1016/j.procbio.2019.05.025

DO - 10.1016/j.procbio.2019.05.025

M3 - Article

VL - 84

SP - 103

EP - 111

JO - Process Biochemistry

T2 - Process Biochemistry

JF - Process Biochemistry

SN - 1359-5113

ER -